Stock KNE KANE BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Kane Biotech Inc.

Equities

KNE

CA4838092084

Market Closed - Toronto S.E.
Other stock markets
 03:55:13 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.125 CAD -3.85% Intraday chart for Kane Biotech Inc. 0.00% +56.25%
Apr. 18 Transcript : Kane Biotech Inc. - Special Call
Apr. 15 Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Kane Biotech Inc. - Special Call
Kane Biotech to Host Investor Webinar
GL
Kane Biotech Up 12% After Reporting Closing of STEM Animal Health Sale
MT
Kane Biotech Announces Closing of the Sale of STEM Animal Health to Dechra Veterinary Products
GL
Dechra Veterinary Products, Inc. completed the acquisition of 66.66% stake in STEM Animal Health Inc. from Kane Biotech Inc..
CI
Kane Biotech Agrees to Sell its Interest in STEM Animal Health for US$8 Million
MT
Canadian Investment Regulatory Organization Trade Resumption - KNE
AQ
Kane Biotech Announces Agreement in Principle for the Sale of its Interest in STEM Animal Health
GL
Canadian Investment Regulatory Organization Trading Halt - KNE
AQ
Transcript : Kane Biotech Inc., Q4 2023 Earnings Call, Mar 26, 2024
Kane Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Kane Biotech Brief: Says otal revenue for the three months ended December 31, 2023 was $764,997
MT
Kane Biotech Announces Fourth Quarter and Full Year 2023 Financial Results
GL
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
MT
Kane Biotech Extends Exclusivity Period on its Offer for its Interest in STEM Animal Health
GL
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
GL
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
AQ
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
GL
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
GL
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KNE Stock
  4. News Kane Biotech Inc.